Immunochemistry EQA Programmes

Our Immunochemistry EQA programmes support laboratories in assessing, comparing, and improving performance across a wide range of immunochemical tests used in clinical diagnostics.

These schemes strengthen quality assurance in areas such as inflammatory markers, cerebrospinal fluid analysis, complement pathways, and tumour marker–related investigations, helping laboratories maintain accuracy, meet accreditation standards, and ensure confidence in patient results.

For those seeking to understand what immunochemistry is or what an immunochemistry test involves, these programmes cover many of the core assays used to evaluate immune function, inflammation, infection, neurological disease, and protein abnormalities.

Alongside our EQA services, here at UK NEQAS IIA we offer further educational support through the Digital Academy, offering commentaries, webinars, and technical presentations that reinforce continual professional development.

All programmes below are administered by UK NEQAS for Immunology, Immunochemistry & Allergy (UK NEQAS IIA) and are available to national and international participants.

Programmes in this category

• Alpha 1 Antitrypsin Phenotype Identification (SER/037)
  Assessment of AAT quantitation and phenotype identification to support diagnosis of AAT deficiency, COPD, emphysema, and associated liver disease.
  
  
• Alkaline Phosphatase (ALP) Isoenzymes (SER/056)
  Evaluation of ALP isoenzyme identification to support investigation of raised ALP and differentiation of hepatic, bone, and other sources.
  
  
• Beta 2 Microglobulin (SER/013)
  EQA for accurate β2-microglobulin measurement, supporting monitoring of B-cell malignancies and renal conditions.
  
  
• C1 Inhibitor & Functional Complement (SER/033)
  Assessment of C1 inhibitor and complement activity measurement, supporting accurate investigation of hereditary angioedema and complement pathway disorders.
  
  
• C-Reactive Protein (SER/014)
  Evaluation of CRP measurement accuracy, supporting monitoring of inflammation, sepsis, and infection severity.
  
  
• CSF Beta 2 Transferrin & Beta Trace Protein (SER/046)
  Assessment of β2-transferrin and β-trace protein testing, supporting confirmation of cerebrospinal fluid leakage in suspected rhinorrhoea or otorrhoea.
  
  
• CSF Haem Pigments (SER/042)
  Evaluation of haem pigment identification and bilirubin/oxyhaemoglobin quantitation to support accurate investigation of suspected subarachnoid haemorrhage.
  
  
• CSF Oligoclonal Bands (SER/015)
  EQA for oligoclonal band detection in CSF, supporting reliable assessment in the diagnosis of multiple sclerosis and related neurological disease.
  
  
• CSF Proteins & Biochemistry (SER/041)
  Assessment of CSF protein, albumin, IgG, glucose and lactate measurement, supporting biochemical evaluation in neurological conditions.
  
  
• Interleukin-6 (SER/060)
  Evaluation of IL-6 measurement accuracy, supporting consistent monitoring of inflammatory responses and immune dysregulation.
  
  
• Pilot - Point-of-Care CRP (POC/555)
  EQA for point-of-care CRP devices, supporting reliable testing in primary care and near-patient settings.
  
  
• Procalcitonin (SER/061)
  PCT measurement accuracy, supporting monitoring of inflammation, sepsis, and infection severity.
  
  
• Ultrasensitive CRP (uCRP) (SER/028)
  Assessment of ultrasensitive CRP measurement used in neonatal infection screening and cardiovascular risk assessment.

How participation supports quality

Taking part in these programmes enables laboratories to:

• Strengthen understanding of what immunochemistry tests measure and how they support diagnosis.
• Benchmark performance against peer laboratories in the UK and internationally.
• Support accreditation and regulatory compliance.
• Maintain analytical accuracy across a broad range of immunochemical markers.
• Access expert educational materials through the Digital Academy.

Register Today

Don’t hesitate to contact us for further information, and register here today.